By Richa Naidu VEVEY, Switzerland, August 17 (Reuters) – Nestle is seeking to turn the rise of GLP-1 weight-loss drugs from a threat into a business opportunity, using artificial intelligence and
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
China new home prices extend declines in July
BEIJING, Aug 17 (Reuters) - China's new home prices were stagnant in July, underscoring the…
Hayden Panettiere, 'Heroes' and 'Nashville' actress, dies at 36, US media reports
By Ananya Palyekar Aug 16 (Reuters) - American actress Hayden Panettiere, famed for roles in…
Anthropic IPO valuation hinges on $190-200 billion 2028 revenue forecast, sources say
By Echo Wang Aug 14 (Reuters) - As Anthropic prepares for what could be one…
